Pancreatic Cancer Therapeutics Market Share Analysis and Regional Trends 2021
Pancreatic Cancer Therapeutics Market By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Others), By Type (Exocrine Pancreas Cancer, Endocrine Pancreas Cancer), By End Users (Hospitals, Clinics, Research Institutes, Others), by Region
(EMAILWIRE.COM, May 05, 2017 ) According to the report Pancreatic Cancer Market, published by Market Data Forecast, the global market is projected to reach USD 2.99 billion by 2021, at a CAGR of 7.54% from 2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/
Pancreatic cancer is caused by the uncontrolled growth of cells in the pancreas. This abnormal, unrestrained growth of cells results in the formation of lumps of tissue, widely referred to as tumors. The presence of tumors prevents the normal functioning of pancreas. The occurrence and mortality rate of pancreatic cancer is more in men than in women. SEER estimates that pancreatic cancer accounts for around seven percent of the total cancer deaths in the US annually. While total cancer incidence and death rates are decreasing, the incidence and death rates for pancreatic cancer are rapidly burgeoning. Pancreatic cancer is projected to overtake colorectal cancer to become the second top cause of cancer-related death in the United States around 2020. Also, pancreatic cancer is the only major cancer with a five-year relative survival rate in the single digits, which is about a lowly 8%.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/request-sample
Having less than five-year survival, the pancreatic cancer market has one of the highest unmet therapy needs in the oncology market across the globe. Clearly, this is also the most challenging aspect that this market needs to address. Given the nature of pancreatic cancer, treatments often return insufficient results. This challenge is yet another barrier to the growth of this market. Technologies are yet to develop fully for the timely diagnosis of this cancer type, which results in the diagnosis of majority of pancreatic cancer patients at an advanced stage of the disease. This explains the high mortality rates associated with pancreatic cancer. Estimates show that only a small percentage, that is about 12% to 15% of the patients is diagnosed early enough to be treated with surgical procedures, drugs, and chemotherapy.
Request Customization at http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/customize-report
Product Segmentation:
Based on type of treatment
Surgery
Chemotherapy
Radiation Therapy
Others
Based on type
Exocrine Pancreas Cancer
Endocrine Pancreas Cancer
Based on End-users
Hospitals
Clinics
Research Institutes
Others
Geographical Segmentation
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/inquire
Key players in the pancreatic cancer market include Eli Lilly, Amgen, Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc. and NewLink Genetics Corp.
Buy now https://www.marketdataforecast.com/cart/buy-now/global-pancreatic-cancer-market-1277
About us
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing an appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
For full report refer to http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/
Pancreatic cancer is caused by the uncontrolled growth of cells in the pancreas. This abnormal, unrestrained growth of cells results in the formation of lumps of tissue, widely referred to as tumors. The presence of tumors prevents the normal functioning of pancreas. The occurrence and mortality rate of pancreatic cancer is more in men than in women. SEER estimates that pancreatic cancer accounts for around seven percent of the total cancer deaths in the US annually. While total cancer incidence and death rates are decreasing, the incidence and death rates for pancreatic cancer are rapidly burgeoning. Pancreatic cancer is projected to overtake colorectal cancer to become the second top cause of cancer-related death in the United States around 2020. Also, pancreatic cancer is the only major cancer with a five-year relative survival rate in the single digits, which is about a lowly 8%.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/request-sample
Having less than five-year survival, the pancreatic cancer market has one of the highest unmet therapy needs in the oncology market across the globe. Clearly, this is also the most challenging aspect that this market needs to address. Given the nature of pancreatic cancer, treatments often return insufficient results. This challenge is yet another barrier to the growth of this market. Technologies are yet to develop fully for the timely diagnosis of this cancer type, which results in the diagnosis of majority of pancreatic cancer patients at an advanced stage of the disease. This explains the high mortality rates associated with pancreatic cancer. Estimates show that only a small percentage, that is about 12% to 15% of the patients is diagnosed early enough to be treated with surgical procedures, drugs, and chemotherapy.
Request Customization at http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/customize-report
Product Segmentation:
Based on type of treatment
Surgery
Chemotherapy
Radiation Therapy
Others
Based on type
Exocrine Pancreas Cancer
Endocrine Pancreas Cancer
Based on End-users
Hospitals
Clinics
Research Institutes
Others
Geographical Segmentation
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-pancreatic-cancer-market-1277/inquire
Key players in the pancreatic cancer market include Eli Lilly, Amgen, Inc., Celgene Corp., F. Hoffmann-La Roche, Clovis Oncology Inc., Pfizer, Novartis AG, Threshold Pharmaceuticals Inc., Aduro BioTech Inc., Infinity Pharmaceuticals Inc. and NewLink Genetics Corp.
Buy now https://www.marketdataforecast.com/cart/buy-now/global-pancreatic-cancer-market-1277
About us
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing an appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results